The digitalization of the US healthcare system, driven by the 2014 “Meaningful Use” legislation, makes real-world data (RWD) almost infinitely available and allows the analysis of vast information representing actual medical practice. However, studies using RWD have not yet achieved the level of credibility and sophistication like randomized clinical trials (RCT) with their very detailed guidelines and regulations. The two major sources for RWD in medical research are Electronic Medical Records (EMR) and insurance “claims data”. Both data sources have their limitations in completeness, quality, and longevity.
This webinar will:
- Discuss strengths and limitations of data
- Introduce methodologies
- Demonstrate how RWD/RWE can answer vital questions for which RCT would be too time-consuming, less generalizable, or too costly for an individual sponsor
- Present options that ensure a robust evolution from RWD to real-world evidence (RWE)